Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis
Open Access
- 1 July 2021
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 157, 60-65
Abstract
No abstract availableKeywords
Funding Information
- Chongqing Municipal Health and Family Planning Commission
- Chongqing Science and Technology Development Foundation
This publication has 17 references indexed in Scilit:
- Which cancer type has the highest risk of COVID-19 infection?Journal of Infection, 2020
- Covid-19 and lung cancer: A greater fatality rate?Lung Cancer, 2020
- Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort studyThe Lancet Oncology, 2020
- Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital SystemCancer Discovery, 2020
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, ChinaJAMA Oncology, 2020
- Coronavirus Disease-2019 in Cancer Patients. A Report of the First 25 Cancer Patients in a Western Country (Italy)Future Oncology, 2020
- Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 OutbreakCancer Discovery, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- The nuts and bolts of PROSPERO: an international prospective register of systematic reviewsSystematic Reviews, 2012
- Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication biasJournal of Cranio-Maxillofacial Surgery, 2011